CDKN2A and acute lymphoblastic leukemia: In support of the existence of an antagonistic relationship between E2A-PBX1 and CDKN2A in the clinical context, deletions affecting CDKN2A at chromosome band 9p21 are exceptionally prevalent amongst human ALL samples associated with t(1;19) [43].